Discover how Bayer AG’s Consumer Health division is planning on rebounding from its “disappointing” performance over the past several years in this insightful HBW Insight article.
Based on remarks from Consumer Health President Heiko Schipper at Bayer AG’s Q4 2018 capital markets day, you’ll discover what key challenges are facing the company, which brand categories have been tapped for divestment, and how innovative brand building and a renewed focus on the North American market are some of the initiatives planned to bring Bayer back into single digit growth by 2022.
Based on remarks from Consumer Health President Heiko Schipper at Bayer AG’s Q4 2018 capital markets day, you’ll discover what key challenges are facing the company, which brand categories have been tapped for divestment, and how innovative brand building and a renewed focus on the North American market are some of the initiatives planned to bring Bayer back into single digit growth by 2022.
